Cell Cryopreservation Equipment Market Revenue Grows at a CAGR of 11.44%.

Introduction

Straits Research released its highly anticipated report, “Global Cell Cryopreservation Equipment Market Size & Outlook, 2026-2034”. According to the Straits Research, the market size is valued at USD 3.46 billion in 2025 and is anticipated to grow to USD 9.14 billion by 2034, growing at a CAGR of 11.44% from 2026-2034.

Market Dynamics

The cell cryopreservation equipment market is driven by rising adoption of long-term cell storage across biopharmaceutical manufacturing, regenerative medicine research, and fertility preservation programs. Increasing use of stem cells, primary cells, and bioproduction cell lines in therapeutic development and clinical studies expands demand for freezers and liquid nitrogen storage systems that support stable preservation over extended durations. Growth of biobanks and expanding inventories of stored biological samples further reinforce sustained equipment deployment across research and healthcare settings.

Despite steady demand, the market faces restraints related to high capital expenditure and operational complexity associated with cryogenic infrastructure. Ultra low temperature freezers and liquid nitrogen supply tanks require substantial upfront investment, along with recurring costs linked to maintenance, energy consumption, and safety compliance. These factors can limit adoption among smaller research institutes and regional laboratories, slowing replacement cycles and new installations.

The market presents opportunities through increasing establishment of decentralized cell storage facilities and contract cryopreservation service providers. Expansion of regional biobanks, cell therapy manufacturing sites, and fertility clinics creates demand for modular and scalable equipment platforms that can be integrated within varied laboratory environments. Growing emphasis on standardized storage practices and long term sample traceability across distributed networks supports future adoption of advanced cryopreservation equipment solutions.

Market Highlights

• Equipment: Based on Equipment, the liquid nitrogen supply tanks segment dominated the market with a revenue share of 40.12%.
• Application: Based on Application, the stem cells segment dominated the market with 31.23%.
• End Use: Based on End-Use, the bio-pharmaceutical & pharmaceutical companies segment dominated the market with a revenue share of 37.89%.
• Regional Insights: North America held a dominant share of the global market, accounting for 41.14% in 2025.

Competitive Players

1. Thermo Fisher Scientific Inc.
2. Chart Industries, Inc.
3. PHC Holdings Corporation
4. Eppendorf SE
5. Merck KGaA
6. Panasonic Corporation
7. Azenta, Inc.
8. Cryoport, Inc.
9. BioLife Solutions, Inc.
10. Taylor-Wharton Cryogenics, LLC
11. Worthington Industries, Inc.
12. Helmer Scientific Inc.
13. VWR International, LLC
14. Haier Biomedical
15. Linde plc
16. Air Liquide S.A.
17. ThermoGenesis Holdings, Inc.
18. Others

Recent Developments

• April 2024: Thermo Fisher Scientific Inc. launched TSX Universal Series ULT freezers, which are certified ENERGY STAR and provide improved performance, quicker recovery, and 33% energy savings for environmentally friendly laboratory operations.

Segmentation

1. By Equipment (2026-2034)
   1. Freezers
   2. Incubators
   3. Liquid Nitrogen Supply Tanks
2. By Application (2026-2034)
   1. Stem Cells
   2. Reproductive Cells
   3. Bioproduction Cell Lines
   4. Primary Cells
   5. Others
3. By End-use (2026-2034)
   1. Biopharmaceutical & Pharmaceutical Companies
   2. Academic and Research Institutes
   3. Biobanks
   4. IVF Clinics
   5. Others